Zacks Research Issues Positive Outlook for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Equities research analysts at Zacks Research increased their Q2 2026 earnings per share (EPS) estimates for Agilent Technologies in a research report issued to clients and investors on Wednesday, December 11th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $1.47 per share for the quarter, up from their prior forecast of $1.46. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share. Zacks Research also issued estimates for Agilent Technologies’ Q4 2026 earnings at $1.70 EPS and FY2027 earnings at $6.67 EPS.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the business earned $1.38 EPS. The firm’s quarterly revenue was up .8% on a year-over-year basis.

Several other research firms have also recently weighed in on A. Stifel Nicolaus reissued a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Wells Fargo & Company lowered their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. StockNews.com downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, November 26th. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Finally, JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies presently has a consensus rating of “Hold” and an average target price of $143.62.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $139.00 on Monday. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The company has a 50-day moving average price of $136.75 and a 200 day moving average price of $136.37. Agilent Technologies has a 12-month low of $124.16 and a 12-month high of $155.35. The stock has a market cap of $39.94 billion, a P/E ratio of 31.45, a PEG ratio of 4.48 and a beta of 1.07.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently made changes to their positions in the stock. Crewe Advisors LLC raised its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth about $28,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies during the second quarter worth approximately $29,000. Ashton Thomas Securities LLC acquired a new position in Agilent Technologies in the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC increased its stake in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 95 shares during the last quarter. 87.42% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 19.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.